Loading clinical trials...
Loading clinical trials...
A Multicenter, Randomized, Factorial, Double-blinded, Double-dummy Phase Ⅲ Trial to Evaluate the Efficacy and Safety of the Coadministration of Valsartan 160mg and Rosuvastatin 20mg in Comparison to Each Component Administered Alone in Patients With Hypertension and Hyperlipidemia
Conditions
Interventions
Valsartan 160mg
Rosuvastatin 20mg
+2 more
Locations
1
South Korea
Yonsei University Health System Severance Hospital
Seoul, South Korea
Start Date
April 1, 2012
Primary Completion Date
March 1, 2013
Completion Date
March 1, 2013
Last Updated
December 15, 2014
NCT06062394
NCT07079592
NCT07230730
NCT07334834
NCT07311941
NCT06903897
Lead Sponsor
LG Life Sciences
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions